CYP19A1 and breast cancer: Firstly, testosterone under the action of aromatase can be converted into estradiol in adipose tissue and other organs, including breast tumor cells, and thus realize its BC risk effects through estrogen-mediated pathophysiological mechanisms that are risky for BC [13].